March 17 (Reuters) - Pulse Biosciences Inc PLSE.O:
PULSE BIOSCIENCES ANNOUNCES STRATEGIC ALIGNMENT TO ACCELERATE CARDIAC CATHETER PROGRAM FOLLOWING EXCEPTIONAL LONG-TERM AFIB CLINICAL DATA
Source text: ID:nBw7n96HQa
Further company coverage: PLSE.O
((((Reuters.Briefs@thomsonreuters.com;));))